Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer Patients
Status:
Suspended
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
The 105-15-201 study is designed to assess the effectiveness and tolerability of the
combination of heat-activated target therapy (radiotherapy + hyperthermia +
lyso-thermosensitive liposomal doxorubicin) of loco-regional relapse in breast cancer
patients.